City of Hope National Medical Center

City of Hope National Medical Center was paid $175.72M by Medicaid between Jan 2018 and Dec 2024, across 412 billing codes. Its largest line is J9271, Injection, pembrolizumab, 1 mg — 12% of everything it billed.

33Billing provider infoCITY OF HOPE NATIONAL MEDICAL CENTER
DUARTE, CA 91010

33aNPI1750358297assigned 03/03/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$175.72M

24GClaims1,273,291

24DCodes billed412

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#6 of 410

Median peer was paid$6.90M

This provider vs. median25×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	103,155	$13.03M
2019	108,544	$10.67M
2020	126,462	$10.13M
2021	160,441	$19.62M
2022	175,324	$27.61M
2023	295,730	$47.10M
2024incomplete	303,635	$47.55M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
J9271	Injection, pembrolizumab, 1 mg	12%	3,611	2,777	$21.33M
77386		4.8%	6,719	785	$8.50M
78815	Positron emission tomography (PET) for limited area imaging	4.6%	5,736	5,627	$8.16M
J9299	Injection, nivolumab, 1 mg	4.6%	1,978	1,319	$8.09M
J9144	Injection, daratumumab, 10 mg and hyaluronidase-fihj	3.4%	1,319	827	$6.01M
J9306	Injection, pertuzumab, 1 mg	2.9%	1,142	824	$5.12M
80053	Comprehensive metabolic panel	2.8%	92,593	61,318	$4.92M
J9358	Injection, fam-trastuzumab deruxtecan-nxki, 1 mg	2.8%	1,270	593	$4.84M
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	2.6%	3,574	2,623	$4.51M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	2.5%	37,635	22,884	$4.47M
J2505	Injection, pegfilgrastim, 6 mg	2.5%	1,877	1,424	$4.38M
J0897	Injection, denosumab, 1 mg	2.4%	3,869	3,659	$4.24M

400 more codes

Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	2.0%	4,141	$3.54M
74178		1.9%	5,768	$3.31M
71260	Computed tomography, thorax, diagnostic; with contrast material	1.8%	11,999	$3.21M
0510		1.8%	44,843	$3.11M
38204		1.7%	651	$3.00M
96375	Therapeutic injection; each additional sequential IV push	1.6%	25,848	$2.77M
Q5117	Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg	1.5%	2,858	$2.70M
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	1.3%	830	$2.25M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	1.3%	93,378	$2.23M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	1.1%	3,208	$1.91M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.0%	84,672	$1.82M
88185		<1%	2,614	$1.65M
P9037	Platelets, pheresis, leukocytes reduced, irradiated, each unit	<1%	2,349	$1.64M
J9354	Injection, ado-trastuzumab emtansine, 1 mg	<1%	428	$1.47M
77334		<1%	2,692	$1.42M
J0185	Injection, aprepitant, 1 mg	<1%	8,416	$1.40M
81455		<1%	526	$1.35M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	8,442	$1.27M
77301		<1%	1,051	$1.26M
77373		<1%	891	$1.24M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	2,016	$1.23M
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	2,177	$1.22M
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	5,689	$1.04M
77412		<1%	7,641	$1.01M
J2353	Injection, octreotide, depot form for intramuscular injection, 1 mg	<1%	254	$1.01M
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	4,588	$1.01M
78816		<1%	574	$926K
J9202	Goserelin acetate implant, per 3.6 mg	<1%	1,496	$920K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	<1%	841	$890K
88341		<1%	3,328	$876K
96417		<1%	10,916	$861K
77300		<1%	2,063	$853K
0710		<1%	2,509	$842K
96367		<1%	9,982	$735K
74183		<1%	1,475	$711K
96415		<1%	8,631	$705K
38222		<1%	977	$664K
83735		<1%	20,939	$664K
71250		<1%	2,687	$661K
0370		<1%	2,022	$659K
72197		<1%	1,192	$648K
Q5115	Injection, rituximab-abbs, biosimilar, (truxima), 10 mg	<1%	738	$634K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	14,795	$605K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	1,025	$604K
J9035	Injection, bevacizumab, 10 mg	<1%	283	$578K
77336		<1%	5,326	$555K
96361	Intravenous infusion, hydration; each additional hour	<1%	5,927	$537K
J9173	Injection, durvalumab, 10 mg	<1%	92	$513K
83615		<1%	27,506	$495K
Z7500		<1%	14,558	$492K
87497		<1%	6,068	$491K
77338		<1%	1,082	$474K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	4,792	$474K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	1,234	$470K
0760		<1%	11,274	$458K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	947	$428K
99203	Doctor's office visit, new patient (routine)	<1%	1,836	$396K
88342		<1%	3,998	$390K
J3490	Unclassified drugs	<1%	14,538	$383K
J9395	Injection, fulvestrant, 25 mg	<1%	1,587	$374K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	3,790	$365K
99070		<1%	17,222	$340K
96416		<1%	2,636	$326K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	11,387	$322K
99499		<1%	734	$321K
76641		<1%	2,821	$320K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	3,422	$313K
80197		<1%	4,848	$304K
A9270	Non-covered item or service	<1%	6,953	$301K
86885		<1%	6,781	$300K
77295		<1%	312	$296K
82784		<1%	13,672	$294K
88261		<1%	753	$286K
78306		<1%	999	$283K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	2,331	$275K
88360		<1%	1,524	$265K
70491		<1%	1,012	$262K
96377		<1%	3,006	$259K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	4,796	$252K
93307		<1%	732	$249K
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	<1%	205	$243K
J9305	Injection, pemetrexed, not otherwise specified, 10 mg	<1%	601	$243K
81479	Unlisted molecular pathology procedure	<1%	500	$242K
J9264	Injection, paclitaxel protein-bound particles, 1 mg	<1%	329	$241K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	3,286	$236K
96402		<1%	4,094	$235K
81378		<1%	272	$233K
J1442	Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram	<1%	1,015	$222K
P9073	Platelets, pheresis, pathogen-reduced, each unit	<1%	380	$221K
77290		<1%	608	$220K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	522	$220K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	4,912	$216K
86900		<1%	8,103	$213K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	3,626	$208K
99213	Doctor's office visit, returning patient (routine)	<1%	6,115	$207K
85027		<1%	12,799	$207K
84100		<1%	11,743	$202K
86901		<1%	8,069	$193K
96401		<1%	3,013	$190K
J9070	Cyclophosphamide, 100 mg	<1%	1,020	$190K
36430		<1%	1,603	$180K
J9171	Injection, docetaxel, 1 mg	<1%	621	$179K
88184		<1%	2,008	$179K
A9595	Piflufolastat f-18, diagnostic, 1 millicurie	<1%	57	$174K
A9585	Injection, gadobutrol, 0.1 ml	<1%	5,043	$173K
82378		<1%	7,496	$173K
84443	Thyroid stimulating hormone (TSH)	<1%	9,140	$170K
96368		<1%	4,005	$167K
80195		<1%	2,487	$161K
86923		<1%	1,935	$158K
76536		<1%	1,369	$153K
88271		<1%	485	$150K
71046	Radiologic examination, chest; 2 views	<1%	2,267	$149K
80048	Basic metabolic panel (calcium, ionized)	<1%	4,182	$144K
81382		<1%	272	$140K
0250		<1%	9,759	$139K
84550		<1%	9,585	$131K
77470		<1%	494	$130K
88307		<1%	747	$128K
96409		<1%	1,311	$126K
86316		<1%	8,099	$123K
77065	Tomosynthesis, mammo	<1%	1,504	$122K
99221		<1%	814	$118K
77066	Tomosynthesis, mammo	<1%	1,185	$117K
84439		<1%	7,364	$117K
36591		<1%	4,976	$115K
96523		<1%	718	$112K
82565		<1%	9,668	$111K
J3489	Injection, zoledronic acid, 1 mg	<1%	2,106	$111K
J1453	Injection, fosaprepitant, 1 mg	<1%	767	$109K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	15,043	$108K
J7050	Infusion, normal saline solution, 250 cc	<1%	26,615	$108K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	5,105	$107K
G0498	Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion	<1%	1,065	$101K
0391		<1%	318	$100K
85007		<1%	5,348	$100K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	2,115	$96K
88237		<1%	868	$96K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	2,119	$95K
82948		<1%	7,376	$94K
85610		<1%	5,681	$94K
J2997	Injection, alteplase recombinant, 1 mg	<1%	795	$93K
99199	Unlisted special service, procedure or report	<1%	994	$91K
94729		<1%	842	$90K
J7030	Infusion, normal saline solution , 1000 cc	<1%	9,059	$90K
80061	Lipid panel	<1%	4,651	$89K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	16,029	$89K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	3,580	$88K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	1,363	$84K
J9190	Injection, fluorouracil, 500 mg	<1%	6,046	$82K
94727		<1%	684	$82K
83883		<1%	5,053	$81K
Q3014	Telehealth originating site facility fee	<1%	4,619	$80K
84165		<1%	3,668	$80K
J9267	Injection, paclitaxel, 1 mg	<1%	2,925	$78K
96411		<1%	1,655	$77K
77280		<1%	362	$76K
C9290	Injection, bupivacaine liposome, 1 mg	<1%	266	$75K
77080		<1%	1,025	$74K
81001		<1%	4,752	$74K
88381		<1%	405	$73K
0761		<1%	603	$73K
88108		<1%	1,139	$72K
81268		<1%	371	$71K
85730		<1%	4,148	$71K
82728		<1%	2,988	$70K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	299	$69K
A0429	Emergency ambulance ride, basic life support	<1%	510	$68K
86334		<1%	1,809	$66K
J9308	Injection, ramucirumab, 5 mg	<1%	29	$66K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	2,337	$65K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	360	$64K
82248		<1%	5,730	$64K
88275		<1%	121	$63K
72158		<1%	96	$62K
J9206	Injection, irinotecan, 20 mg	<1%	1,871	$61K
77049		<1%	63	$60K
83721		<1%	3,775	$59K
J9075	Injection, cyclophosphamide, not otherwise specified, 5 mg	<1%	529	$59K
86304		<1%	2,439	$58K
J9045	Injection, carboplatin, 50 mg	<1%	2,424	$57K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	18,331	$56K
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	1,413	$55K
76830	Ultrasound, transvaginal	<1%	352	$55K
87086	Culture, bacterial; quantitative colony count, urine	<1%	2,194	$53K
94010		<1%	438	$50K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	1,477	$47K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	1,556	$46K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	15,612	$45K
81371		<1%	49	$45K
87040		<1%	582	$43K
0636		<1%	4,051	$43K
83036	Hemoglobin; glycosylated (A1C)	<1%	3,528	$42K
99152		<1%	792	$42K
J9041	Injection, bortezomib, 0.1 mg	<1%	625	$42K
88280		<1%	731	$41K
81267		<1%	273	$41K
77387		<1%	132	$40K
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	<1%	1,618	$38K
86301		<1%	1,835	$35K
82746		<1%	1,815	$34K
0401		<1%	455	$34K
A9581	Injection, gadoxetate disodium, 1 ml	<1%	399	$34K
82105		<1%	582	$34K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	5,876	$32K
84153		<1%	2,731	$32K
87070		<1%	587	$32K
84403		<1%	1,848	$31K
36593		<1%	492	$31K
G0378	Hospital observation service, per hour	<1%	538	$31K
J9317	Injection, sacituzumab govitecan-hziy, 2.5 mg	<1%	48	$31K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	2,428	$30K
90734		<1%	26	$30K
90677		<1%	108	$29K
88311		<1%	1,131	$29K
99238	Hospital discharge day management, 30 minutes or less	<1%	1,023	$29K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	2,669	$29K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	377	$28K
82607		<1%	2,013	$28K
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	<1%	44	$26K
88285		<1%	680	$26K
82533		<1%	991	$25K
J2704	Injection, propofol, 10 mg	<1%	4,881	$23K
71045	Radiologic examination, chest; single view	<1%	482	$23K
36592		<1%	1,436	$23K
86480		<1%	648	$22K
83690		<1%	694	$22K
84481		<1%	1,315	$22K
86140		<1%	1,372	$21K
93971		<1%	145	$21K
Q5112	Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg	<1%	27	$21K
76770		<1%	143	$21K
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	849	$20K
93970		<1%	42	$19K
97802		<1%	181	$19K
84466		<1%	1,386	$19K
96156		<1%	189	$18K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,219	$17K
82570		<1%	1,995	$17K
86833		<1%	151	$16K
86832		<1%	147	$16K
83970		<1%	499	$16K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	52	$16K
0270		<1%	2,180	$16K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	195	$15K
81025		<1%	960	$14K
82150		<1%	521	$14K
J9000	Injection, doxorubicin hydrochloride, 10 mg	<1%	659	$13K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	620	$13K
77417		<1%	238	$13K
83540		<1%	1,384	$13K
88323		<1%	100	$13K
99218		<1%	84	$13K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	10,807	$12K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	2,419	$11K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	82	$11K
87340		<1%	582	$11K
99153	Mod sedat endo service >5yrs	<1%	245	$10K
87799		<1%	151	$10K
90686		<1%	525	$10K
82043		<1%	1,446	$10K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	342	$10K
87077		<1%	573	$10K
84702		<1%	607	$9K
82550		<1%	410	$9K
86300		<1%	465	$9K
77063	Screening digital breast tomosynthesis, bilateral	<1%	378	$9K
J9060	Injection, cisplatin, powder or solution, 10 mg	<1%	600	$9K
J1170	Injection, hydromorphone, up to 4 mg	<1%	2,333	$8K
87186		<1%	335	$8K
77332		<1%	42	$8K
86704		<1%	449	$7K
84478		<1%	241	$7K
99234		<1%	769	$7K
86803		<1%	374	$7K
93017		<1%	39	$7K
Q5101	Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram	<1%	99	$7K
J0690	Injection, cefazolin sodium, 500 mg	<1%	1,690	$7K
88142		<1%	195	$7K
72157		<1%	13	$7K
84480		<1%	461	$6K
84156		<1%	466	$6K
96450		<1%	15	$6K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	2,653	$6K
J0461	Injection, atropine sulfate, 0.01 mg	<1%	1,540	$6K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	3,664	$5K
Z7610		<1%	524	$5K
88374		<1%	16	$5K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	2,083	$5K
88313		<1%	88	$5K
81002		<1%	792	$5K
84432		<1%	406	$5K
86359		<1%	94	$5K
86706		<1%	253	$5K
77293		<1%	12	$5K
81206		<1%	28	$5K
86800		<1%	554	$5K
85384		<1%	205	$4K
81207		<1%	28	$4K
0360		<1%	54	$4K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	212	$4K
52000		<1%	112	$4K
93702		<1%	40	$4K
85046		<1%	450	$4K
90670		<1%	14	$4K
88264		<1%	33	$4K
99217		<1%	126	$4K
86870		<1%	69	$3K
36561		<1%	25	$3K
0160		<1%	97	$3K
J1644	Injection, heparin sodium, per 1000 units	<1%	1,033	$3K
90746		<1%	44	$3K
J2785	Injection, regadenoson, 0.1 mg	<1%	37	$3K
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	29	$3K
86360		<1%	52	$3K
0001A		<1%	68	$3K
76642		<1%	30	$2K
77790		<1%	26	$2K
83550		<1%	476	$2K
87205		<1%	178	$2K
83605		<1%	147	$2K
86960		<1%	123	$2K
90715		<1%	43	$2K
90713		<1%	43	$2K
97167		<1%	24	$2K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	28	$2K
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	1,415	$2K
94726		<1%	20	$1K
88312		<1%	39	$1K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	2,798	$1K
76937		<1%	47	$1K
82681		<1%	27	$1K
82024		<1%	60	$1K
J9999	Not otherwise classified, antineoplastic drugs	<1%	339	$1K
89051		<1%	54	$1K
0002A		<1%	31	$1K
85652		<1%	207	$1K
J2060	Injection, lorazepam, 2 mg	<1%	954	$1K
76942		<1%	27	$1K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	12	$1K
90662		<1%	216	$1K
85651		<1%	33	$1K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	764	$1K
77001		<1%	15	$1K
82523		<1%	279	$1K
87517		<1%	57	$1K
90648		<1%	68	$990.71
J1756	Injection, iron sucrose, 1 mg	<1%	27	$942.59
J2270	Injection, morphine sulfate, up to 10 mg	<1%	111	$928.49
A4648	Tissue marker, implantable, any type, each	<1%	13	$915.99
77062		<1%	33	$906.70
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	59	$850.56
J9370	Vincristine sulfate, 1 mg	<1%	95	$796.87
0300		<1%	209	$780.46
71020		<1%	27	$658.51
J3480	Injection, potassium chloride, per 2 meq	<1%	727	$654.99
85049		<1%	43	$650.21
96150		<1%	13	$645.76
88173		<1%	12	$563.64
86592		<1%	185	$542.54
82945		<1%	36	$507.91
82977		<1%	47	$491.00
83001		<1%	24	$479.47
84157		<1%	35	$462.32
82575		<1%	28	$439.59
87075		<1%	12	$406.06
97162		<1%	12	$401.60
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	140	$376.60
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	72	$373.00
83010		<1%	14	$349.68
45330		<1%	12	$315.23
88172		<1%	12	$270.26
0305		<1%	163	$266.00
86376		<1%	40	$263.61
88300		<1%	12	$255.89
87493		<1%	12	$254.28
83002		<1%	12	$229.36
90472	Immunization administration, each additional vaccine (list separately)	<1%	14	$227.30
0306		<1%	55	$192.00
90656		<1%	13	$187.90
86644		<1%	28	$180.64
83516		<1%	27	$171.75
G0008	Administration of influenza virus vaccine	<1%	223	$166.22
86705		<1%	14	$163.45
0301		<1%	204	$157.81
83520		<1%	14	$144.37
84155		<1%	13	$114.48
J1171	Injection, hydromorphone, 0.1 mg	<1%	30	$76.48
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	<1%	85	$74.73
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	13	$67.70
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	29	$65.22
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	15	$56.10
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	15	$48.45
J1956	Injection, levofloxacin, 250 mg	<1%	12	$46.82
81003		<1%	15	$35.08
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	32	$30.28
J9260	Injection, methotrexate sodium, 50 mg	<1%	22	$28.76
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	18	$9.61
0260		0%	84	$0.00
0335		0%	59	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTREMONTI, YVETTE (CFO)